Just Earth News | @justearthnews | 04 May 2021, 01:20 am Print
Pfizer-BioNTech Image: Pixabay
Washinton/Sputnik: The US Food and Drug Administration (FDA) is preparing to approve the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15, The New York Times reported, citing federal officials.
The authorization is expected to come early next week, the report said on Monday.
Pfizer announced several weeks ago that none of the adolescents who have received the vaccine during trials have contracted a symptomatic case of COVID-19.
However, plans to vaccinate teens and children, who rarely contract serious cases of the illness, have sparked debate, the report added, as many question whether excess US vaccines could be put to better use on adults in other countries.
- Microplastics become chemically active in water, raising health concerns: Study
- Struggling with sleep? Samsung Health's latest update promises more personalised guidance
- Eating sugar while on antibiotics? New study raises concerns about gut health
- High Cholesterol? Eating oats for just 2 days may help lower LDL levels
- This everyday snack could hold a clue to diabetes prevention, study finds
-1791127926.jpg "Image of the day: October 4, 2026")
